| 000 | 02844nam a2200349 c 4500 | ||
|---|---|---|---|
| 001 | 76434 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040224.0 | ||
| 008 | 121214s2013 gw | s |||| 0|eng d | ||
| 020 | _a9783642335709 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aQP632.B66 _bB68 2013 EB |
|
| 082 | 0 | 4 | _a615 |
| 245 | 0 | 0 |
_aBotulinum Neurotoxins _cedited by Andreas Rummel, Thomas Binz |
| 260 |
_aBerlin, Heidelberg _bSpringer International Publishing _c2013 |
||
| 300 |
_a1 recurso en línea (X, 321 p.) _b48 ilustraciones |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 1 |
_aCurrent Topics in Microbiology and Immunology _x0070-217X _v364 |
|
| 520 | _aBotulinum neurotoxins are the most toxic natural substances and represent a major threat to the population when intentionally released in bioterrorist attacks. On the other hand, during the past two decades botulinum neurotoxins have become established as indispensable drugs for the treatment of a variety of severe neurological disorders. The need for efficient countermeasures as well as the expansion into additional fields of therapeutic application, call for comprehensive information on the botulinum neurotoxin molecules and their mode of action. Our knowledge of this subject has made great strides in recent years, setting the stage for the development of new botulinum neurotoxin-based molecules and novel applications. This book reviews the current status of basic botulinum neurotoxin research. The first part describes the genetic variability of the toxin-producing bacteria, and sheds light on each step from toxin ingestion to the abrogation of synaptic signaling including the intestinal passage and absorption, nerve cell binding and entry, and intracellular substrate cleavage. The remaining chapters detail progress made in detection methods for botulinum neurotoxins, the development of botulinum neurotoxin inhibitors, and strategies to refine the neurotoxins for further medicinal applications by means of recombinant technologies. | ||
| 942 |
_2lcc _cLE |
||
| 988 | _aEBOOK, EBSPRINGERrevisando | ||
| 650 | 7 |
_aToxina botulínica _0comprobar BNE20012840947 _2embne _9159095 |
|
| 700 | 1 |
_aRummel, Andreas _eeditor literario _985511 _0Local |
|
| 700 | 1 |
_aBinz, Thomas _eeditor literario _985512 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-33570-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783642335709 | ||
| 907 |
_a.b12820520 _b10-10-17 _c01-10-14 |
||
| 998 |
_am _a_alco _a_vill _b28-04-17 _cm _dz _ef _feng _ggw _h0 |
||
| 945 |
_aQP632 .B66 B68 2013 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11549737 _z06-04-17 |
||
| 999 |
_c76434 _d76434 _x1 |
||